AU Patent

AU2014280951B2 — Biphenylcarboxamide derivatives as hedgehog pathway modulators

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2016-10-13 · 10y expired

What this patent protects

C:\NRPonbUlCC\KXG\J3"2679_1 DOC.IM5/201 2 The invention provides a method for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function…

USPTO Abstract

C:\NRPonbUlCC\KXG\J3"2679_1 DOC.IM5/201 2 The invention provides a method for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula 1. Ra R3 RG R7 Re 0 Y2 R9

Drugs covered by this patent

Patent Metadata

Patent number
AU2014280951B2
Jurisdiction
AU
Classification
—
Expires
2016-10-13
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.